Background: More than three quarters of cases of atherosclerosis are directly caused by abnormalities in lipids profile, which is known as dyslipidemia. Atherosclerosis is considered one of the most causes leading to death around the world. the treatment of dyslipidemia is considered one of the important measures to decrease the risk of cardiovascular events. Effective use of statins leads to improvement in overall mortality and reduce the number of cardiovascular events up to 20%. Methodology: We conducted this review using a comprehensive search of MEDLINE, PubMed, and EMBASE, January 1985, through February 2017. The following search terms were used: statin, hyperlipidemia, advantages of statin therapy, disadvantages of statin therapy, a...
This Review is intended to help clinicians, patients, and the public make informed decisions about s...
The explosion of medical knowledge and the importance and real reductions in adverse cardiovascular ...
Statins are the mainstay of lipid-lowering therapy because of their well-established efficacy for re...
<p>Statins are used to reduce morbidity and mortality in patients with a high risk of cardiovascular...
Cardiovascular disease (CVD) is the leading cause of death worldwide. Dyslipidemia is one of the cau...
Despite significant advances in prevention and treatment, cardiovascular disease continues to be the...
Background: Type 2 diabetics are at high risk of atherosclerosis and cardiovascular (CV) events due ...
Importance of the field: Lipid-modifying drugs are therapeutic options that have been shown to reduc...
The use of statins has recently attracted the attention of clinicians. Indeed, statins are probably ...
One in 4 Americans >40 years of age takes a statin to reduce the risk of myocardial infarction, isch...
Introduction: Dyslipidemia mainly refers to a disbalance of any form of lipid in the body. Any disba...
Purpose of review: Dyslipidaemias are a major risk factor for cardiovascular disease (CVD); in parti...
With the increasing global burden of dyslipidemia over the past 30 years, it is estimated that more ...
Coronary heart disease (CHD) is a major cause of morbidityand mortality. Recent evidence supports th...
Statins have been prescribed to the masses as primary and secondary prevention for coronary disease ...
This Review is intended to help clinicians, patients, and the public make informed decisions about s...
The explosion of medical knowledge and the importance and real reductions in adverse cardiovascular ...
Statins are the mainstay of lipid-lowering therapy because of their well-established efficacy for re...
<p>Statins are used to reduce morbidity and mortality in patients with a high risk of cardiovascular...
Cardiovascular disease (CVD) is the leading cause of death worldwide. Dyslipidemia is one of the cau...
Despite significant advances in prevention and treatment, cardiovascular disease continues to be the...
Background: Type 2 diabetics are at high risk of atherosclerosis and cardiovascular (CV) events due ...
Importance of the field: Lipid-modifying drugs are therapeutic options that have been shown to reduc...
The use of statins has recently attracted the attention of clinicians. Indeed, statins are probably ...
One in 4 Americans >40 years of age takes a statin to reduce the risk of myocardial infarction, isch...
Introduction: Dyslipidemia mainly refers to a disbalance of any form of lipid in the body. Any disba...
Purpose of review: Dyslipidaemias are a major risk factor for cardiovascular disease (CVD); in parti...
With the increasing global burden of dyslipidemia over the past 30 years, it is estimated that more ...
Coronary heart disease (CHD) is a major cause of morbidityand mortality. Recent evidence supports th...
Statins have been prescribed to the masses as primary and secondary prevention for coronary disease ...
This Review is intended to help clinicians, patients, and the public make informed decisions about s...
The explosion of medical knowledge and the importance and real reductions in adverse cardiovascular ...
Statins are the mainstay of lipid-lowering therapy because of their well-established efficacy for re...